Latest Equity Capital Raise News

Qoria Limited is moving towards a transformative merger with US-based Aura Consolidated Group, Inc., combining complementary digital safety platforms and targeting growth through a $100 million capital raise and ASX listing.

Australian Dairy Nutritionals has locked in a $1.5 million secured loan facility with RELI Capital to shore up working capital and support its FY26 strategy, using its Yaringa dairy farm as collateral.

Jayride Group continues its pivot to a SaaS mobility platform across Australasia and Southeast Asia, managing tight cash flow and planning a capital raise to sustain operations and support ASX reinstatement.

Cyprium Metals has made substantial progress on its Nifty Copper Complex restart, targeting copper cathode production by September 2026 while securing A$41 million to fuel exploration and growth.

Great Southern Mining has initiated deep diamond drilling at its Golden Boulder discovery in Western Australia, supported by government co-funding and a recent capital raise. This marks a pivotal step in exploring the source of multiple gold mineralisation trends within the Duketon Gold Project.

Genesis Energy has opened a NZ$300 million rights offer priced at NZ$2.05 per share, marking a 10.8% discount to the theoretical ex-rights price, aiming to accelerate its growth pipeline following a recent NZ$100 million placement.

TerraCom Limited reported a significant half-year loss amid falling coal prices and production challenges, completing a $56 million capital raise to strengthen its financial position.

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.

Alpha HPA Limited reports strong progress on its HPA First Project Stage 2 construction and secures binding supply contracts for 2026 in the booming semiconductor sector, while launching a $225 million equity raise to fund expansion.

Wisr Limited has reported a robust Q2FY26 with a 23% jump in its loan book and a 16% revenue increase, underpinned by a surge in loan originations and improved credit metrics. The fintech lender also strengthened its balance sheet through a capital raise and debt refinancing, setting the stage for profitability later this year.